FLT3LG - a biomarker reflecting clinical responses to the immunogenic cell death inducer oxaliplatin

The fms-related tyrosine kinase 3 (FLT3) ligand (FLT3LG) binds to FLT3 on dendritic cells to stimulate their differentiation and expansion, hence facilitating tumor antigen cross-presentation and anticancer immune responses. A recent study by Abrahamsson et al. demonstrates that, in patients receivi...

Full description

Bibliographic Details
Main Authors: Jonathan G. Pol, Julie Le Naour, Guido Kroemer
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1755214

Similar Items